Current Allergy and Asthma Reports

, Volume 7, Issue 4, pp 255–263

What’s new in blistering disorders?


DOI: 10.1007/s11882-007-0038-7

Cite this article as:
Chaudhari, P. & Marinkovich, M.P. Curr Allergy Asthma Rep (2007) 7: 255. doi:10.1007/s11882-007-0038-7


From the characterization of new animal models for the study of disease pathogenesis, to the demonstration of new therapeutic modalities, many developments have revolutionized the field of autoimmune bullous diseases in the past several years. This review highlights many of the significant advances that have taken place in the diagnosis, pathogenesis, and treatment options for pemphigus, pemphigoid, epidermolysis bullosa acquisita, and immunoglobulin (Ig) A-mediated bullous disorders.

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Stanford University School of Medicine and VA Palo Alto Medical CenterStanfordUSA